SelectQuote (SLQT) Q1 2027 Earnings Call Transcript
SelectQuote (SLQT) reported Q1 2027 revenue of $280M, down 15% YoY, with an adjusted EBITDA loss of $17M. Senior revenue fell 14% YoY, while Medicare Advantage policies decreased 18%. Healthcare Services revenue dropped 16%, but EBITDA grew 56%. The company maintained full-year guidance and plans a reverse stock split. Management prioritized profitability over volume, leveraging AI and operational efficiencies.
How this was made

The 30-second read
Why it matters
Management reiterated FY2027 guidance while emphasizing operational efficiency (AI call screening, pharmacy management system) and cash-flow ramp expectations; however, reported Senior and Healthcare Services revenue declines reflect ongoing policy and pricing headwinds.
Market read
Traders can update models for FY2027 revenue, adjusted EBITDA, and operating cash flow based on reiterated guidance and segment-level KPI shifts tied to IRA and AEP dynamics.
What to watch
Reverse stock split mechanics and the Nov. 10 shareholder meeting could affect near-term liquidity and sentiment, while the IRA impact may evolve as CMS commission rates and carrier plan features change during AEP.
Background
SelectQuote’s fiscal Q1 2027 call focused on Medicare Advantage enrollment season (AEP), Senior agent force reduction, and SelectRx pharmacy services performance amid Inflation Reduction Act drug pricing effects.
Ticker impact
SelectQuote reported Q1 results and reiterated FY2027 revenue ($1.35B-$1.45B) and adjusted EBITDA ($90M-$115M) guidance while discussing IRA headwinds and a reverse split plan.
Likely mixed reaction, with upside from reiterated FY2027 targets and margin/cash-flow improvements offset by revenue headwinds from the Inflation Reduction Act and shrinking Medicare Advantage policy counts.
The article contains fresh, company-specific quarterly metrics and explicit FY2027 guidance ranges, plus management commentary on IRA-driven revenue pressure and operational efficiency initiatives.
Market effects
Highlights Medicare Advantage enrollment-season disruption and AI-driven agent productivity as a competitive operating lever for Medicare-focused service providers.
None material indicated beyond US Medicare Advantage dynamics.
Limited, company-specific US healthcare services and Medicare Advantage enrollment season.
Counterpoint
The revenue decline and policy count drop may signal demand softness or competitive share loss, and margin improvement could be partly timing-driven rather than durable.
Key entities
- companySelectQuote, Inc.
Reported Q1 2027 results, segment KPIs, and reiterated FY2027 guidance; discussed IRA headwinds and a reverse stock split plan.
- executiveTim Danker
CEO who attributed top-line pressure to the Inflation Reduction Act and discussed AEP disruption and agent-force sizing.
- executiveRyan Clement
CFO who discussed capital adequacy and reiterated FY2027 guidance ranges.




